Category: Approval/Launch Region: Asia · India Company: Zydus Lifesciences Ltd

Zydus Gets Us Fda Final Nod For Febuxostat Tablets For Treating High Uric Acid

Zydus Gets Us Fda Final Nod For Febuxostat Tablets For Treating High Uric Acid
According To The Statement From Zydus, Febuxostat Tablets Are Indicated To Lower Hyperuricemia (High Uric Acid In The Blood) In Patients With Gout Who Have Been Treated With Allopurinol That Did Not Work Well Or Cannot Be Treated With Allopurinol&Nbs

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!